In a breast tumor xenograft model, the MCT-1 oncogene increases the in vivo tumorgenicity of MCF7 cells by promoting angiogenesis and inhibiting apoptosis. Increases in the tumor microvascular density are accompanied by a strong reduction in the levels of the angiogenesis inhibitor thrombospondin-1 (TSP1), but the mechanisms underlying this process are unknown. We show that TSP1 expression is controlled, at least in part, by post-transcriptional events. Using RNA interference to knock down the expression of the RNA-binding protein HuR in MCF7 cells as well as HuR overexpression, we demonstrate that HuR plays an important role in translation of the TSP1 mRNA. Furthermore, employing the RIP-Chip assay yielded 595 transcripts with significantly altered binding to HuR in the more tumorigenic breast cancer clones compared with the weakly tumorigenic clones. These mRNAs clustered in several pathways implicated in the transformed phenotype, such as the RAS pathway (involved in mitogenesis), the PI3K pathway (evasion of apoptosis) and pathways mediating angiogenesis and the cellular response to hypoxia. These findings demonstrate for the first time that global changes in HuR-bound mRNAs are implicated in the evolution to a more tumorigenic phenotype in an in vivo tumor model and underscore the role of global mRNA-protein interactions toward tumor progression.
Introduction
In a human xenograft model, the MCT-1/MCTS-1 (multiple copies in T-cell lymphoma 1) oncogene, hereafter named MCT-1 (Prosniak et al., 1998) , promotes the transition to a more aggressive phase in breast cancer progression by enhancing invasiveness and decreasing apoptosis (thereby promoting the formation of larger tumors), and increases angiogenesis by reducing the expression of the angiogenesis inhibitor TSP1/ THBS-1 (thrombospondin 1; Levenson et al., 2005) , hereafter named TSP1. Given that natural angiogenesis inhibitors appear to have low toxicity, and that newly formed vessels are more sensitive to angiogenesis inhibitors than quiescent vessels, there is growing interest in developing TSP1-based cancer therapies (Ren et al., 2006) . Previous data demonstrate that overall vascular density correlates to poor cancer prognosis (Weidner, 1998) and that TSP1 expression is inversely correlated with malignant progression of breast cancer (Zabrenetzky et al., 1994; Watnick et al., 2003) . Thus, understanding the mechanism of action and regulation of TSP1 during angiogenesis and tumor progression has become important.
RNA turnover and translation are critical posttranscriptional mechanisms of gene regulation in mammalian cells, primarily governed by the interaction of mRNA with specific RNA-binding proteins (RBPs). Many ribonucleoprotein (RNP) associations implicating sequences present in the 3 0 -untranslated regions (3 0 UTRs) of mRNAs have been shown to regulate the transport, turnover and translation rates of the target mRNAs (Piecyk et al., 2000; Bevilacqua et al., 2003; Mazan-Mamczarz et al., 2006; Keene, 2007; Liao et al., 2007) . Although the nucleotide composition of such regulatory sequences is very variable, often they are rich in adenines and uracils (AREs). The presence of AREs in the TSP1 3 0 -UTR suggest that the regulation of TSP1 on the mRNA level may be an important mechanism involved in controlling TSP1 gene expression and plays a critical role in tumor progression.
In this investigation, we set out to formally examine the molecular mechanisms regulating the expression of TSP1 in a model of increased tumorigenicity elicited through the enhanced expression of the MCT-1 oncogene (Levenson et al., 2005) . Systematic study of several RBPs implicated in post-transcriptional gene regulation (collectively termed translation and turnover regulatory (TTR) RBPs or TTR-RBPs, Pullmann et al., 2007) to the TSP1 mRNA revealed that HuR/ELAVL1, hereafter named HuR specifically associated with TSP1 mRNA and that this interaction was dramatically decreased in highly tumorigenic clones (with increased MCT-1 levels). HuR regulates the stability and translation of many ARE-containing mRNAs and thereby controls the expression of the encoded proteins, often involved in the cell division cycle, carcinogenesis, senescence and the immune and stress responses (Brennan and Steitz, 2001; Kullmann et al., 2002; Galba´n et al., 2003; Mazan-Mamczarz et al., 2003; Lopez de Silanes et al., 2004; Lal et al., 2005) . In keeping with these functions, we found that HuR enhanced the translation of the TSP1 mRNA in this model system. Interestingly, however, in cells with a more aggressive phenotype (expressing high levels of MCT-1), HuR dissociated from TSP1 mRNA, in turn causing a reduction in TSP1 mRNA translation. Given the proposed function of HuR in cancer, we examined the global interaction of HuR with other target mRNAs in this model of increased tumorigenicity. We found that the MCT-1 enhanced breast cancer tumorigenicity was associated with significant alterations in the association of HuR with functional subsets of mRNAs. In accordance with the post-transcriptional operon model (Keene and Tenenbaum, 2002) , our findings suggest that HuR functions as a downstream effector of MCT-1-regulated gene expression in cancer: HuR's association with mRNAs that encode tumor-promoting proteins increases (as shown for cyclins and prothymosin a (Wang et al., 2000a; Lal et al., 2005) ) and its association with mRNAs that inhibit tumorigenesis decreases, as shown here for TSP1 mRNA.
Results
Increased expression of MCT-1 reduces the translation of angiogenesis inhibitor TSP1 Mammary epithelial adenocarcinoma MCF7 cells were stably transfected with MCT-1, and two clones that overexpressed MCT-1 protein, N1 and N7, were isolated and described previously in a human xenograft mouse model (Levenson et al., 2005) . Here, we used the N1 and N7 clones from the in vivo tumor progression model to examine the mechanism(s) underlying the decreased TSP1 production in the MCF7 cells with a more aggressive phenotype.
We first examined the expression levels of TSP1 from MCF7 cells transfected with empty Vector (V), the pooled population overexpressing MCT-1 (M), and the two MCT-1 overexpressing clones (N1 and N7). The levels of TSP1 protein decreased markedly (B5-fold) in all MCT-1 overexpressing cell lines compared to Vector cells ( Figure 1a) . Although the possible contributions of altered trancription or TSP1 protein stability were not formally ruled out, the observed reduction in TSP1 protein abundance was not accompanied by a comparable decrease in TSP1 mRNA levels (Figure 1b ) or TSP1 mRNA stability (Supplementary information, Figure  S1 ), suggesting that the MCT-1-mediated decrease of TSP1 might be effected by altered translation.
To test that TSP1 translation might be reduced in MCT-1 overexpressing cells, cytoplasmic extracts from Vector and MCT-1 cell lines were subjected to sucrose density gradient analysis and the TSP1 mRNAs associated with the translational machinery were monitored. The fractions containing the nontranslating RNA (fractions 1-5) and containing polysomes (fractions 6-11) were pooled and TSP1 mRNA abundance was measured by real-time quantitative PCR (RTqPCR; Figure 1c ). As shown, TSP1 mRNA levels in polysomal fractions were decreased in all MCT-1 overexpressing populations compared to V cells: it was 60% lower in M cells, and 70% in both N1 and N7 clones. The reduced presence of TSP1 mRNA in the translating fractions suggested that the heightened expression of MCT-1 in MCF7 cells decreased the translation of TSP1 protein. Further evidence that the translation of TSP1 was inhibited with increased expression of MCT-1 was obtained using a de novo translation assay that measured the rate of nascent TSP1 protein synthesis. Vector (V) and MCT-1 transfected lines (M, N1 and N7) were briefly incubated in the presence of L-[ While the short (20 min) incubation period for labeling is inefficient and yields relatively weak signals, it allows the detection of newly translated protein and minimizes the potential contribution of protein degradation. These data revealed about five fold lower de novo protein biosynthesis of TSP1 in all MCT-1 overexpressing cell lines that was consistent with the decreased association of TSP1 mRNA with polysomes ( Figure 1d ). Together, these data show that in the highly tumorigenic MCF7 clones expressing elevated levels of the MCT-1 oncogene, the translation of the TSP1 mRNA were diminished, leading to the decreased TSP1 protein biosynthesis.
HuR binds TSP1 mRNA Given previous reports linking RBPs to post-transcriptional gene regulation (Keene, 2001; Wilusz and Wilusz, 2004) , the existence of U-rich and AU-rich regions in the long (B2 kb) TSP1 3 0 UTR (Figure 2a) , and the fact that the TSP1 3 0 UTR contains six computationally predicted hits of a previously identified HuR motif (Lopez de Silanes et al., 2004) , we directly examined whether this RBP might be involved in the post-transcriptional regulation of TSP1 expression. The association of several TTR-RBPs with endogenous TSP1 mRNA was tested by IP analysis using MCF7 cell lysates and antibodies recognizing the major TTR-RBPs (HuR, AUF-1/ hnRNPD, TIA-1 and TIAR). The association of RBPs with TSP1 mRNA was monitored by RTqPCR analyses of mRNAs isolated from the IP material using TSP1 mRNA-specific primers ( Figure 2b ). As shown, the TSP1 PCR product was highly enriched in the IP material obtained with anti-HuR antibody compared with the low level of amplification seen in control immunoglobulin G (IgG) IP and in the IPs obtained using anti-AUF-1, anti-TIA-1 and anti-TIAR antibodies. To monitor the evenness of loading of the input material, we amplified GAPDH mRNA, which showed equal low-level background contamination in all of the IP samples tested (not shown).
To precisely determine the region of the TSP1 mRNA that interacted with HuR, we synthesized several biotinylated transcripts spanning the TSP1 mRNA (Figure 2c , schematic) and used them in pull down assays (see Materials and methods). HuR prominently bound the terminal 3 0 untranslated region (3 0 UTR) ('3 0 D' fragment) but not the coding region (CR), 5 0 UTR transcripts and other parts of 3 0 UTR. AUF-1 was found to bind the same '3 0 D' TSP1 sequence, although binding appeared to be significantly weaker, while TIA-1 did not bind any TSP1 transcripts (Figure 2c ). These data indicate that TSP1 mRNA is a specific target of RBP HuR both when assessing the endogenous mRNA and when testing a recombinant transcript in vitro, and the binding occurs in the terminal region of the TSP1 3 0 UTR.
Binding of the HuR to the TSP1 mRNA decreased when using lysates from cells with increased MCT-1 levels Given the reported ability of HuR and other ELAV proteins to influence mRNA stability and/or translation (Brennan and Steitz, 2001; Gorospe, 2003) , we set out to directly investigate the potential contribution of HuR to the reduction of TSP1 expression in MCT-1 expressing MCF7 cells. First, we examined the association of TSP1 mRNA with HuR by carrying out RNP IP reactions Changes in TSP1 total mRNA levels (relative to GAPDH mRNA) assessed by RT-qPCR for Vector (V), and MCT-1 overexpressiong cells; mass culture (M) and two clones (N1 and N7). Graphs represent the means and s.e.m. from three independent experiments. Clone N1 showed less than two fold difference compared to Vector (V); t-test value of Po0.01. (c) The relative association of the TSP1 mRNA with polysomes was tested by preparing cytoplasmic lysates from MCF7 stable cell lines (described in Figure 1a ), fractionating them through sucrose gradients and collecting 11 fraction for analysis. Representative polysome distribution profile obtained after centrifugation of cytopasmic lysates over sucrose gradient (inset); free mRNA, monosomes and polysomes of increasing molecular weight are indicated. The levels of TSP1 mRNA in the pooled 1-5 fractions comprised the nontranslating RNA, and pooled 6-11 fractions comprised the translating RNA were quantified by real-time quantitative PCR (RT-qPCR) and normalized to GAPDH mRNA. Graphs represent the means and s.e.m. from six independent experiments; Po0.01 significantly different compared to Vector (V) by t-test. (d) Newly translated TSP1 protein was assessed by 20 min incubation of each stable transfected MCF7 cell lines (described in Figure 1a Figure 1a ). However, we did not find any differences in the association of the other RBPs studied (AUF-1, TIA-1 and TIAR) to the TSP1 mRNA when comparing cells that expressed different MCT-1 levels ( Figure 3a ; Supplementary information, Figure S3 ).
Modulation of HuR expression influences TSP1 translation
To study the functional consequences of decreased HuR-TSP1 mRNA interaction on TSP1 mRNA and protein levels, we carried out experiments in which HuR expression in MCF7 cells were modified (see Material and methods). Overexpression of HuR increased TSP1 protein abundance in both the Vector and MCT-1 overexpressing populations (Figure 4a ). HuR overexpression in Vector cells had lower effect (B2-fold) on TSP1 production (the cells might have reached the maximum levels of TSP1 expression possible), while MCT-1 cells showed strikingly heightened (>8-fold) TSP1 levels compared with cells transfected with the empty tandem affinity purification (TAP) vector despite the fact that they consistently showed a reduced magnitude of HuR overexpression. TSP1 mRNA levels, as measured by RT-qPCR analysis, was modestly elevated after HuR overexpression in both cell lines (Figure 4b ). Taking into consideration the earlier reports showing that HuR can promote the translation of target mRNAs (Kullmann et al., 2002; Galba´n et al., 2003; Mazan-Mamczarz et al., 2003; Lal et al., 2005) and our findings that TSP1 mRNA was much less abundant in translating fractions and that TSP1 protein was less actively translated in the more malignant lines (Figures 1c and d) , it was important to investigate whether the TSP1 translation was regulated by HuR. First, we examined whether the positive effect of HuR on TSP1 expression levels in MCF7 cells was due to an enhanced association of TSP1 mRNA with actively translating polysomes. When pooling sucrose gradient fractions according to translational activity (no translation, low translation or active translation), cells expressing elevated levels of HuR (HuR-TAP) shifted the distribution of TSP1 mRNA toward the heavier polysomal fractions (fractions 10 and 11) in both the Vector and MCT-1 overexpressing populations ( Figure 4c ). The translational status of the TSP1 mRNA was also monitored by directly assessing de novo protein synthesis assay (Figure 4d ). These data revealed more than five fold increase in TSP1 translation in cells overexpressing HuR (HuR-TAP) relative to control transfection (TAP) in both cell lines (Vector, MCT-1), providing additional in vivo evidence that HuR enhances TSP1 mRNA translation. Reduction of HuR levels by transfecting MCF7 cells with targeting HuR siRNA effectively decreased the HuR levels in both Vector cells and MCT-1 overexpressing populations to o10% of the HuR levels seen in control transfection populations. Decreasing HuR expression (HuR siRNA) caused more than two fold decrease in TSP1 protein abundance in both cell lines studied ( Figure 5a ). As measured by RT-qPCR, the reduction was not influenced significantly by lower total TSP1 mRNA levels in HuR siRNA cells ( Figure 5b ). As in the HuR overexpression experiments, the translational status of TSP1 mRNA was tested by monitoring by distribution of TSP1 mRNA in polysomal fractions along a sucrose gradient in control and HuR-silenced cell populations. HuR-silenced groups (HuR siRNA) showed that TSP1 mRNA was more abundant in the Figure 1a ) were employed for immunoprecipitation (IP) assays, using antibodies that recognized HuR, AUF-1/hnRNP D, TIA-1 or TIAR. RNA was isolated and reverse transcription (RT) following qPCR was performed. Graph represents the mean and s.e.m. from three independent assays. Po0.02 versus Vector (V) in IPs with HuR antibody. (b) Representative IP assays performed as described in but followed by western blot analysis to assess the abundance of HuR protein in the IP material.
Global changes in HuR-bound mRNAs and tumor progression K Mazan-Mamczarz et al low translating fractions (fractions 6 and 7) and less abundant in the actively translating fractions (10 and 11) in both Vector and MCT-1 cells (Figure 5c ). Importantly, nascent TSP1 translation (as measured by in vivo incorporation of radiolabeled amino acids into newly synthesized TSP1) was two fold lower in both Vector and MCT-1 MCF-7 populations with silenced HuR (HuR siRNA; Figure 5d ). Taken together, our findings support the concept that HuR associates with the TSP1 mRNA and enhances its translation. Furthermore, in MCT-1 expressing cells, HuR association with TSP1 mRNA is reduced, and consequently TSP1 mRNA and protein levels decrease. Global changes in HuR-bound mRNAs and tumor progression K Mazan-Mamczarz et al regulated at the post-transcriptional level through the action of specific RBPs that recognize sequence elements shared among the mRNAs that encode such genes (Keene and Tenenbaum, 2002; Keene et al., 2006) . Therefore, we sought to investigate whether MCT-1 elicited a similar modulation of binding of HuR to target mRNAs associated with the MCT-1-induced tumorigenic phenotype. To this end, we studied the subsets of mRNAs that were coregulated with TSP1 mRNA through the modulation of their association with the HuR in the MCT-1 expressing cells. We performed RNP-IP analysis of MCF7 Vector and MCT-1 overexpressing cell lysates using anti-HuR antibody. The identification of mRNAs in each IP group was achieved by reverse transcription followed by cDNA array hybridization (see Materials and methods). Microarray analysis showed that out of 24 000 transcript probes available on the microarray, B9000 mRNAs were associated with HuR and the association of 595 transcripts with HuR was significantly changed (269 reduced, 326 elevated) in more tumorigenic MCT-1 overexpressing cells (Z ratio difference values greater or less than ±1.5, P-value o0.05). Functional analysis clustered those 595 genes into numerous different biological pathways. In Figure 6a , gray bars correspond to pathways exhibiting genes whose binding to HuR significantly decrease in the MCT-1 overexpression group (Z score less than À1.5). Several of the pathways represented in these populations are signal transduction cascades implicated in neoplastic transformation, including genes involved in cell-cycle arrest, angiogenesis and apoptosis (such as p21/CDKN1A, TSP1 and Bax). Black bars represent pathways containing genes whose association with HuR significantly increases in the MCT-1 overexpression group (Z score more than 1.5). Such pathways are involved in survival signaling and Global changes in HuR-bound mRNAs and tumor progression K Mazan-Mamczarz et al proliferation (as PIK3R1/AKT, RAS/MEK/ERK). Importantly, TSP1 mRNA was found among the genes with significantly decreased association with HuR in MCT-1 overexpressing cells compared to Vector control populations (Table 1, Supplementary  information Table S1 ). The microarray data provided additional evidence that HuR-TSP1 mRNA complexes dissociated in the more tumorigenic MCF7 populations and further supported the view that HuR is a downstream effector of the protumorigenic gene expression program triggered by MCT-1. See http://www.grc.nia.nih.gov/branches/rrb/ dna/index/dnapubs.htm#2 for complete microarray data. TAKEDA_NUP8_HOXA9_8D_UP  SANA_IFNG_ENDOTHELIAL_UP  ST_TYPE_I_INTERFERON_PATHWAY  IFNAPATHWAY  IFNALPHA_HCC_UP  IFNALPHA_NL_UP  JECHLINGER_EMT_UP  IFNALPHA_NL_HCC_UP  IFNA_HCMV_6HRS_UP  GRANDVAUX_IFN_NOT_IRF3_UP  BECKER_TAMOXIFEN_RESISTANT_UP  RIBAVIRIN_RSV_UP  BRG1_SW13_UP  BECKER_IFN_INDUCIBLE_SUBSET_1  XU_ATRA_PLUSNSC_UP  ET743_SARCOMA_6HRS_UP  IFN_BETA_UP  WIELAND_HEPATITIS_B_INDUCED  FLECHNER_KIDNEY_TRANSPLANT_REJECTION_UP  CISPLATIN_PROBCELL_UP  CELL_CYCLE_ARREST  BRG1_ALAB_DN  BRCA1_MES_UP  ADIPOGENESIS_HMSC_CLASS8_DN  ZELLER_MYC_DN  UVC_LOW_ALL_UP  UVC_LOW_A2_UP  CIS_RESIST_GASTRIC_UP  RADIATION_SENSITIVITY  TRNA_SYNTHETASES  AMINOACYL_TRNA_BIOSYNTHESIS  PROTEASOME  BRCA1_SW480_DN  ACTINYPATHWAY  RAC1PATHWAY  TRKAPATHWAY  PLCPATHWAY  CDC42RACPATHWAY  IDX_TSA_UP_CLUSTER4  MTA3PATHWAY  ST_DICTYOSTELIUM_DISCOIDEUM_CAMP_CHEMOTAXIS  RASPATHWAY  CREBPATHWAY  H2O2_CSBDIFF_C2  NOS1PATHWAY  HYPOXIA Global changes in HuR-bound mRNAs and tumor progression K Mazan-Mamczarz et al Microarray analysis was performed in triplicate and the resulting data were normalized by Z score transformation and tested for significant differences in signal intensity. Differentially expressed genes (with Z ratio >1.5 or oÀ1.5, and fdr o0.3) were organized by the Ingenuity Pathway Analysis into known biological pathways. Probability scores for each functional grouping were calculated based on the chance of mRNA abundance changes predicting these interactions. The significance of each pathway was calculated by using the right-tailed Fisher's exact test. The P-value was calculated by comparing the number of user-specified genes of interest involved in a given pathway relative to the total number of occurrences of these genes in all pathway annotations stored in the knowledge base. Graph shows pathways in which association with HuR significantly decreased with Z score oÀ1.5 (gray bars) or increased with Z score >1.5 (black bars), Po0.05. Pathways and genes involved are described in Table 1 and Supplementary information (Table S1 ). (b) Modulation of HuR levels alters anchorage-independent colony growth in MCT-1 overexpressing MCF7 cells. Twenty-four hours after transfection, cells were cultured in agarose/medium, 1 week later, colonies were counted. Graphs represent the mean and s.e.m. of three independent experiments, Po0.03. Abbreviations: IFN, interferon; MAPK, mitogen-activated protein kinase; UV, ultraviolet. Ingenuity Pathway Analysis identified altered functional pathways by categorizing the genes differentially associated with HuR. Arrows indicate an increased or decreased association with HuR in more tumorigenic MCF7 cells.
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Finally, to demonstrate that altered HuR binding to target mRNAs affects the phenotype of MCT-1 overexpressing MCF7 cells, we carried out soft agar colony formation assays after modulation of HuR levels. As shown, overexpression of HuR increased, while HuR knockdown reduced the ability of MCF7 MCT-1 overexpressing cells to form anchorage-independent colonies (Figure 6b ).
Discussion
We recently demonstrated that MCT-1 promotes the transition to a more aggressive phase in breast cancer progression by increasing tumor angiogenesis. This effect was achieved, at least in part, through the MCT-1-triggered downregulation of an endogenous angiogenesis inhibitor, TSP1 (Levenson et al., 2005) . However, the mechanism(s) underlying the regulation of TSP1 in this model remains unknown. In the light of accumulating evidence that post-transcriptional events critically determine gene expression patterns (Orphanides and Reinberg, 2002) , we set out to study whether the levels of TSP1 were governed by post-transcriptional mechanisms. Using MCF7 cells, we showed that the reduced TSP1 expression in the more aggressive (MCT-1 overexpressing) clones is due to the suppression of TSP1 translation levels, and identify HuR as a major regulatory factor in this process. HuR associated with the 3 0 UTR of the TSP1 mRNA, which bears U-and AU-rich sequences (ARE; Figure 2a) , as revealed by IP followed by either RT-qPCR or microarray analysis. The abundance of the (HuR-TSP1 mRNA) complex decreased dramatically in MCT-1 overexpressing more aggressive cells, in turn decreasing TSP1 translation, and leading to a reduction in TSP1 protein abundance in these cells. Experiments in which the entire TSP1 3 0 UTR was linked to the coding region of the heterologous reporter GFP revealed decreased expression of GFP protein in overexpressing MCT-1 MCF7 cells compared to cells transfected with plasmid containing the GFP coding region alone (Supplementary information, Figure S2) , suggesting the TSP1 3 0 UTR functions to suppress TSP1 expression levels specifically in MCT-1 overexpressing cells. Similar results were obtained for the c-fos and c-myc 3 0 UTR ARE, which destabilized the c-fos and c-myc mRNAs: deletion of this sequence led to increases in mRNA stability, protein abundance and cellular transformation (Meijlink et al., 1985; Hollis et al., 1988; Aghib et al., 1990) .
HuR has been described as a protein that stabilizes many important target mRNAs (that is, VEGF, c-myc, c-fos, TNF-a, cyclin A, cyclin B1, p21 and EGF; as reviewed by Brennan and Steitz, 2001 ). HuR has also been shown to promote the translation of numerous target transcripts independent of its effect on mRNA stability, p53, Pro-Ta, cytochrome c, p27Kip1 and TIA-1 (Millard et al., 2000; Mazan-Mamczarz et al., 2003; Lal et al., 2005; Kawai et al., 2006; Pullmann et al., 2007) , although in some cases, it has also been shown to repress target mRNA translation (p27Kip1, IGF-IR, Wnt5a and various cytokines; Kullmann et al., 2002; Katsanou et al., 2005; Meng et al., 2005; Leandersson et al., 2006) . Most of those reports show enhanced binding of HuR to target transcripts (for example, p21, p53, Pro-Ta and mRNAs) following exposure to different stress stimuli (Wang et al., 2000b; MazanMamczarz et al., 2003; Lal et al., 2005) . Here, we found instead a reduction in the association of HuR and the TSP1 mRNA in MCT-1 overexpressing MCF7 cell lines. Importantly, the dissociation of complexes caused TSP1 mRNA to be less efficiently recruited to translationally active polysomes (Figure 1c) , and less actively translated into protein (Figure 1d) . One recent report demonstrated that the oxidative stresstriggered dissociation of the [HuR-SIRT1 mRNA] complex promoted SIRT1 mRNA decay . Some reports have begun to emerge documenting the dynamic association of RBPs from target mRNAs under a variety of conditions Kim et al., 2007) . Tenenbaum et al. (2000) demonstrated the association and dissociation of specific mRNAs from the HuB RNP in embryonic carcinoma cells following treatment with retinoic acid. A recent study showed that UVC irradiation triggered a decrease in the binding of HuR to cyclin D1 mRNA, and instead promoted the binding of AUF-1/hnRNP D to this mRNA (Lal et al., 2004) . Similarly, HuR transiently dissociated from the cytochrome c mRNA, while the binding of TIA-1 to this transcript increased following endoplasmic reticulum stress . Bhattacharyya et al. (2006) demonstrated that the microRNA miR-122 can bind to the CAT-1 3 0 UTR and repress its translation; HuR was proposed to function by displacing miR-122 from the CAT 3 0 UTR and thereby relieved the miRNA-imposed translational repression. These studies underscore the existence of a complex and dynamic association of RBPs (as well as miRNAs) with a given target mRNA, which can be modulated by different genotoxic stresses and growth conditions, and can vary from transcript to transcript. We hypothesized that another TTR-RBP(s), likely one that represses translation, might displace HuR from the TSP1 in MCT-1 overexpressing cells and suppress TSP1 expression. Other TTR-RBPs studied showed comparatively less enrichment in TSP1 mRNA (Figure 2b ), although the different relative affinities of the antibodies used preclude a direct comparison of the relative ability of each TTR-RBP to associate with the TSP1 mRNA.
HuR was proposed to play a central role in cancer by binding to mRNAs encoding proteins involved in malignant transformation and altering their expression through post-transcriptional mechanisms (Nabors et al., 2001; Lopez de Silanes et al., 2005) . Through its association with target mRNAs, HuR was found to enhance the expression of many of growth-promoting, proliferative, and proto-oncogenic factors like EGF, cyclin A, cyclin B1 and c-myc (Wang et al., 2000a; Sheflin et al., 2004) . It has been postulated that HuR can expand the cell's invasiveness and metastatic ability by elevating the expression of mRNAs encoding MMP-9 (Akool et al., 2003) and MTA1 (Lopez de Silanes et al., 2004) . Finally, HuR was shown to regulate angiogenesis through its binding to mRNAs and elevating of expression of proangiogenic genes such as VEGF and HIF-1 (Levy et al., 1998; Sheflin et al., 2004; Galba´n et al., 2008) . Our findings that the dissociation of HuR negatively impacts upon the expression of the antiangiogenic gene TSP1 are in keeping with the groups of cancer-related mRNAs whose association changes with a more tumorigenic phenotype. Together, an exciting model emerges whereby HuR functions as a downstream effector of cancer-related gene expression. According to this model, in cells with a less tumorigenic phenotype, HuR associates with mRNAs encoding proapoptotic proteins (such as TSP1, CDKN1A and Bax). In cells with a more malignant phenotype, however, HuR switches its mRNA interaction partners, and associates instead with other mRNAs encoding proteins that favor a more tumorigenic phenotype (such as PIK3R1/AKT and RAS/MEK/ERK). A corollary of this model is that MCT-1 functions as a 'master' upstream regulator of the subsets of mRNAs with which HuR associates in cells of each phenotype.
Our findings lend strong support to the 'posttranscriptional operon' model first proposed by Keene and Tenenbaum (2002) . According to this model, RBPs can jointly regulate subsets of mRNAs encoding functionally related proteins. Our microarray analysis yielded 595 transcripts with significantly altered binding to HuR in the more aggressive breast cancer cell lines. These mRNAs clustered in several pathways implicated in malignant transformation/progression, such as the RAS pathway (implicated in mitogenesis), the PI3K pathway (evasion of apoptosis), the hypoxic response and angiogenesis (Hanahan and Weinberg, 2000) . These findings are in keeping with the hypothesis that MCT-1 mediates a more aggressive phenotype in breast carcinoma cells, partially through its ability to redirect the subsets of mRNAs to be expressed in the cell. Our results reported here demonstrate for the first time that the global changes in HuR-bound mRNAs are implicated in the progression to a more malignant phenotype in an in vivo model. In summary, our work reveals a novel mechanism of regulation of cancer-related genes in MCF7 cells. HuR associates with TSP1 mRNA and enhances its translation, however, in cells overexpressing MCT-1, HuR dissociates from the TSP1 mRNA linked to decreases in TSP1 protein synthesis. Importantly, we show herein that knocking down HuR has a significant effect on the ability of MCF7 cells to grow in an anchorage-independent manner. These studies underscore the role of global mRNA-protein interactions toward the development of a more malignant phenotype and suggest that interventions targeting mRNA-protein associations may represent novel treatment strategies for cancer therapy. Additional work will provide a better understanding of the role that post-transcriptional gene regulation plays in tumor development and progression.
Materials and methods
Cell culture, plasmids and transient transfections Mammary epithelial adenocarcinoma MCF7 cells stably transfected with the pLXSN empty vector (Vector) or pLXSN-MCT-1-V5-histidine (MCT-1; Levenson et al., 2005) , were cultured in Dulbecco's modified essential medium (Gibco BRL, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum and antibiotics.
Plasmids used for HuR overexpression (pcDNA3-TAP) were described previously . For HuR RNAi transfections siRNA targeting the HuR coding region (AAGAGGCAATTACCAGTTTCA) and a control siRNA (Qiagen, Valencia, CA, USA) were used at 20 nM. Cells were transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) when plasmids were used and with oligofectamine (Invitrogen) when siRNA were used. Seventy-two hours after transfection, cells were collected for analysis; experiments were performed three times independently.
Cell fractionation
For the whole cell protein lysates B3 Â 10 6 cells were trypsinized and prepared in RIPA buffer (10 mM Tris-HCL (pH 7.4), 1% NP-40, 1 mM EDTA, 0.1% SDS, 150 mM NaCl) as described (Lal et al., 2004) .
Linear sucrose gradient fractionation was prepared as previously described with minor modifications. Briefly, B6 Â 10 6 cells were incubated for 15 min with 100 mg/ml cycloheximide. Cells were lysed in cytoplasmic lysis buffer containing 20 mM Tris-HCl (pH 7.5), 100 mM KCl, 5 mM MgCl 2 , 0.3% IGEPAL CA-630, RNase-OUT (Invitrogen) and, protease inhibitor cocktail for 5 min on ice and centrifuged (10 000 Â g, 10 min, 4 1C). Cytoplasmic extracts were loaded onto the 10-50% sucrose gradients and after centrifugation (Beckman SW41, 35 000 r.p.m., 3 h, 4 1C) the material was fractionated into 1 ml aliquots using a gradient fractionator (Brandel) and monitored by optical density measurement (A 254 ). RNA from fractions was extracted using Trizol reagent.
Western blotting
For Western blot analysis, 50 mg of protein lysates were resolved by SDS-polyacrylamide gel electrophoresis (Invitrogen, Carlsbad, CA, USA) and transferred onto PVDF membranes. Blots were probed with monoclonal antibodies recognizing TSP1 (NeoMarkers, Fremont, CA), HuR (Santa Cruz Biotechnology Inc.), b-Actin (Abcam, Cambridge, UK), a-tubulin (Sigma, St Louis, MO, USA), V5 (MCT-1-V5; Invitrogen), or polyclonal AUF-1/HRNDP antibody (Upstate Biotech., Lake Placid, NY USA). Following incubation with appropriate secondary antibodies, signals were detected by enhanced chemiluminescence (Pierce, Rockford, IL, USA) and quantified by using VisionWorksLS Software (UVP, Upland, CA, USA).
Binding assays; immunoprecipitation of ribonucleoprotein complexes and biotin pull-down Immunoprecipitation of endogenous RNA-protein complexes were carried out as described previously and are explained in detail in Supplementary information.
In vitro transcription of TSP1 transcripts was carried out as described . Oligomers used for amplification of TSP1 fragments for pull-down assay are listed in Supplementary information. After incubating biotinylated transcripts (2 mg) with 40 mg of cytoplasmic lysate, the RBP complexes were isolated with paramagnetic streptavidinconjugated Dynabeads (Dynal), and the pull-down material was analyzed by western blotting.
RT-PCR analysis of RNA RNA from total, polysome or IP material, was reverse transcribed by using iScript cDNA synthesis kit (BioRad, Hercules, CA) following the manufacture's protocol and subjected to real-time qPCR analysis using gene-specific primer pairs: CAGAGGCCAAAGCACTAAGG and TGAG TAAGGGTGGGGATCAG for TSP1 mRNA and, CGG AGTCAACGGATTTGGTCGTAT and AGCCTTCTCCAT GGTGGTGAAGAC GAPDH mRNA. qPCR analysis was performed using iQSYBR Green Supermix (BioRad) and BioRad iCycler instrument. Each reaction was carried out in triplicate and three independent experiments were run. GAPDH cDNA served as the internal control.
In vivo translation Analysis of de novo translation was carried out using the methodology described previously . Briefly, 10 Microarray analysis after IP RNA from IP material was labeled using the Illumina Total Prep RNA Amplification Kit (Ambion, Austin, TX, USA). Biotin-labeled cRNA was hybridized to HumanRef-8 v2 Expression BeadChips (Illumina, San Diego, CA, USA) containing 22 000 transcripts probes per sample. The data were normalized by Z score transformation (Cheadle et al., 2003) and tested for significant differences in signal intensity. Transcripts were considered changed when Z ratios were more then 1.5 or less then À1.5. Ingenuity Systems Pathways Analysis (Ingenuity Systems; Redwood City, CA, USA) was used to identify top network functions involving differentially expressed genes. See Supplementary information and Calvano et al. (2005) for details in array analysis.
Anchorage-independent growth assay Twenty hours after transfection, cells were plated at 7500 cells/ ml in a 1:3 agarose/medium mixture on top of a solidified layer (1:1 agarose/medium) and covered with medium. One week later, colonies were counted under the microscope. Experiments were performed three times independently.
